| Reduced Risk Status: |
|
| IPM Compatibility: |
PER REQUESTOR VERYFGOODFIT, SPIDOXAMAT HAS BEEN DEMONSTRATED TO HAVE EXCELLENT EFFICACY ON HOMOPTERAN PIERCING SUCKING PEST INSECTS INCLUDING APHIDS AND LEAFHOPPERS WHILE SIMULTANEOUSLY BEING VERY SAFE FOR PREDATORY AND PARASITIC BENEFICIAL INSECTS AND MITES. THE EUROPEAN UNION IS IN THE PROCESS OF STRICTLY REGULATING NEONICOTINYL INSECTICIDES IN GENERAL AND IS INSTITUTING AN OUTRIGHT BAN ON THE USE OF IMIDACLOPRID AND CANCELLING ALL OF IMIDACLOPRID’S MRL IN EUROPE. HOP GROWERS WILL HAVE DIFFICULTY CONTROLLING HOMOPTERAN INSECT PESTS AND SPIDOXAMAT IS AN EXCELLENT ALTERNATIVE TO NEONICOTINYL INSECTICIDES.
|
| Reasons for need: |
HOP APHIDS, TWO-SPOTTED SPIDER MITE, LEAFHOPPERS; SPIDOXAMINE IS HIGHLY SELECTIVE ON PIERCING SUCKING INSECTS AND SPIDER MITES SPIDOXAMINE IS VERY SOFT ON BENEFICIAL INSECTS AND MITES.
|
| Requesting State(s): |
KY:Wright, S ; MI:Sirrine, R ; OR:Palacios, M ; WA:Elliot, M* ;
|
| PCR Use Pattern: |
3.32 OZ/A, 2 FOLIAR APPLIC, RETREATMENT INTERVAL 10 DAYS, 21-DAY PHI; MINIMUM 80 GPA FOR FOLIAR APPLIC
|
| EPA Default Residue Trials: |
5/11/12-4
|
| IR-4 Residue Trial Plan: |
5 11 12-4
|
| Residue Protocol Use Pattern: |
USE THE SPIDOXAMAT SG 75 PRODUCT (75% OF SPIDOXAMAT ACTIVE INGREDIENT); MAKE 2 FOLIAR APPLIC OF 0.156 LB AI/A IN >80 GPA MINIMUM, 10-DAY INTERVAL, 21-DAY PHI; ALL APPLIC SHALL INCLUDE A LABELED RATE OF AN ADJUVANT; PER PROTOCOL CHANGE #1, THE RESIDUE STUDY PROTOCOL USE PATTERN IS NOW THE FOLLOWING: THE TEST SUBSTANCE IS CHANGED TO BCS-AA10147 WG 22.2 FORMULATION (CONTAINING 150 G OF FLUPYRADIFURONE AND 72 G OF SPIDOXAMAT PER KG OF FORMULATED PRODUCT); MAKE 1 FOLIAR APPLIC OF 538 G/A OF PRODUCT (0.178 LB AI/A FLUPYRADIFURONE + 0.086 LB AI/A SPIDOXAMAT) IN >80 GPA MINIMUM, 21-DAY PHI; ALL APPLIC SHALL INCLUDE A LABELED RATE OF AN ADJUVANT
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
Blue 12/21
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
THE MFG CHANGED THE TEST SUBSTANCE FOR THIS STUDY AS THEY WILL NOT SUPPORT STAND-ALONE SPIDOXAMAT PRODUCTS FOR FIELD USE AT THIS TIME; THE COMBINATION PRODUCT OF SPIDOXAMAT + FLUPYRADIFURONE WILL NOW BE USED IN THIS STUDY; FLUPYRADIFURONE IS LABELED ON HOPS AND ANALYSIS WILL NOT BE NEEDED FOR THIS COMPOUND:07/22; determined both ai's need analysis, CAR conducted analysis for Spidoxamat, and STR (SynTech) will conduct analysis on Flupyradifurone:04/24/sb
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|